Inflammation status of rabbit carotid artery model endothelium during intermittent hypoxia exposure and its relationship with leptin

Sleep and Breathing

Volumn 13, Issue 3, 2009, Pages 277-283

  Feng, Jing ^a   Chen, Bao Yuan ^a   Cui, Lin Yang ^b   Wang, Bao Li ^a   Liu Chun Xia, X ^a   Chen, Pan Feng ^a   Guo, Mei Nan ^a   Dong, Li Xia ^a   Li, Shuo ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Neurological Institute   (China)

Author keywords

Continuous hypoxia; Endothelium; Inflammation; Intermittent hypoxia; Leptin

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; RAS PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY ENDOTHELIUM; ARTICLE; CAROTID ARTERY DISEASE; CAROTID ARTERY INFLAMMATION; CELL CULTURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DNA BINDING; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HYPOXIA; LUNG PERFUSION; MALE; MICROSCOPE; NONHUMAN; OBESITY; OXYGEN TENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RABBIT; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEEP APNEA SYNDROME;

ANIMALS; ANOXIA; CAROTID ARTERY, COMMON; DNA PRIMERS; DNA, COMPLEMENTARY; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-6; LEPTIN; MALE; PROTEIN-SERINE-THREONINE KINASES; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHOA GTP-BINDING PROTEIN; RNA, MESSENGER; SLEEP APNEA, OBSTRUCTIVE;

EID: 67649646358     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-009-0246-6     Document Type: Article

References (30)

1. McNicholas WT, Bonsignore MR, Management Committee of EU COST ACTION B26 (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: Current evidence, basic mechanisms and research priorities. Eur Respir J 29:156-178
2. Feng J, Chen BY, Guo MN, Cao J, Zhao HY, Liang DC, Zuo AJ (2007) Interleukin-6 and tumor necrosis factor-alpha levels of endothelial cells in different hypoxia modes: In vitro experiment. Zhonghua Yi Xue Za Zhi 87:774-777
3. Feng J, Chen BY, Guo MN, Cao J, Zhao HY, Liang DC, Zuo AJ (2007) Changes of nuclear factor-kappaB and intercellular adhesion molecule-1 in endothelial cells exposed to various intermittent hypoxia. Zhonghua Jie He He Hu Xi Za Zhi 30:202-206
4. Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290:1906-1914
5. Punjabi NM, Polotsky VY (2005) Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99:1998-2007
6. Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A (1994) Sleep apnea and sleep disruption in obese patients. Arch Intern Med 154:1705-1711
7. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J (2000) Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284:3015-3021
8. Newman AB, Foster G, Givelber R, Nieto FJ, Redline S, Young T (2005) Progression and regression of sleep-disordered breathing with changes in weight: The Sleep Heart Health Study. Arch Intern Med 165:2408-2413
9. Tishler PV, Larkin EK, Schluchter MD, Redline S (2003) Incidence of sleep-disordered breathing in an urban adult population: The relative importance of risk factors in the development of sleep-disordered breathing. JAMA 289:2230-2237
10. Fritscher LG, Mottin CC, Canani S, Chatkin JM (2007) Obesity and obstructive sleep apnea-hypopnea syndrome: The impact of bariatric surgery. Obes Surg 17:95-99
11. Grunstein RR, Stenlöf K, Hedner JA, Peltonen M, Karason K, Sjöström L (2007) Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. Sleep 30:703-710
12. Münzberg H, Björnholm M, Bates SH, Myers MG Jr (2005) Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 62:642-652
13. Cinaz P, Bideci A, Camurdan MO, Güven A, Gönen S (2005) Leptin and soluble leptin receptor levels in obese children in fasting and satiety states. J Pediatr Endocrinol Metab 18:303-307
14. Fouillioux C, Contreras F, Lares M, Cano R, Leal E, Arraiz N, Bermúdez V, Velasco M (2008) Metabolic and hemodynamic markers of endothelial dysfunction in patients with hypertension and patients with type 2 diabetes during the cold pressor test. Am J Ther 15:389-396
15. Kim K, Valentine RJ, Shin Y, Gong K (2008) Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults. Metabolism 57:1181-1189
16. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, Guerre-Millo M (2002) Hypoxia-inducible factor transactivates the human leptin gene promoter. J Biol Chem 277:42953-42957
17. Meissner U, Hänisch C, Ostreicher I, Knerr I, Hofbauer KH, Blum WF, Allabauer I, Rascher W, Dötsch J (2005) Differential regulation of leptin synthesis in rats during short-term hypoxia and short-term carbon monoxide inhalation. Endocrinology 146:215-220
18. Cummings KJ, Wilson RJ (2005) Time-dependent modulation of carotid body afferent activity during and after intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol 288:R1571-R1580
19. Etienne-Manneville S, Hall A (2002) Rho GTPase in cell biology. Nature 420:629-635
20. Yamauchi M, Tamaki S, Tomoda K, Yoshikawa M, Fukuoka A, Makinodan K, Koyama N, Suzuki T, Kimura H (2006) Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath 10:189-193
21. Williams A, Scharf SM (2007) Obstructive sleep apnea, cardiovascular disease, and inflammation - is NF-kappaB the key? Sleep Breath 11:69-76
22. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF (2006) Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343:591-596
23. Lentsch AB, Ward PA (2000) The NFkappaBb/IkappaB system in acute inflammation. Arch Immunol Ther Exp (Warsz) 48:59-63
24. Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, Torbenson MS, Polotsky VY (2007) Chronic intermittent hypoxia predisposes to liver injury. Hepatology 45:1007-1013
25. Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5:343-354
26. Matarese G, Mantzoros C, La Cava A (2007) Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis. Curr Pharm Des 13:3676-3680
27. Wójciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ (2001) Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 114:1343-1355
28. Liu HW, Halayko AJ, Fernandes DJ, Harmon GS, McCauley JA, Kocieniewski P, McConville J, Fu Y, Forsythe SM, Kogut P, Bellam S, Dowell M, Churchill J, Lesso H, Kassiri K, Mitchell RW, Hershenson MB, Camoretti-Mercado B, Solway J (2003) The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. Am J Respir Cell Mol Biol 29:39-47
29. Wettschureck N, Offermanns S (2002) Rho/Rho kinase mediated signaling in physiology and pathophysiology. J Mol Med 80:629-638
30. Bishop AL, Hall A (2000) Rho GTPases and their effector proteins. Biochem J 348(Pt 2):241-255